Reduce HAIs with Covalon's Infection Prevention Technology

The Growing Threat of Hospital-Acquired Infections (HAIs)

Every year, millions of patients worldwide suffer from infection prevention technology hospital-acquired infections (HAIs), such as:

MRSA (antibiotic-resistant staph infections)
Catheter-associated UTIs (CAUTIs)
Surgical site infections (SSIs)
Central line-associated bloodstream infections (CLABSIs)

These infections increase hospital stays by 7-10 days and cost healthcare systems billions annually.

Covalon Technologies (https://covalon.com/) is addressing this crisis with next-generation infection prevention technology products designed to protect patients and reduce the risk of healthcare-associated infections (HAIs).

How Covalon's Technology Prevents HAIs

**1. Antimicrobial Medical Device Coatings

CovaGuard™ – Silver-ion coatings for catheters & implants that kill bacteria on contact.
CovaShield™ – Long-lasting protection for surgical tools & implants.

✅ Proven to reduce HAIs by up to 60% in clinical trials.

**2. Advanced Wound Dressings with Infection Control

ColActive® Plus Ag – Silver-infused dressings that prevent wound infections.
CovaWound™ S – Silicone-based foam dressings that block biofilm formation.

✅ Reduces surgical site infections (SSIs) by 45%.

**3. Antimicrobial Surface Barriers

CovaTec® Film – An invisible, alcohol-free barrier that stops bacterial growth on IV sites and wound edges.

✅ Ideal for high-risk ICU and burn patients.

Why Hospitals Are Switching to Covalon's Solutions

Feature	Covalon's Products	Standard Alternatives
Infection Prevention	Proactive antimicrobial tech	Reactive treatment only
Longevity	Days to weeks of protection	Hours to days
Patient Safety	Non-toxic, biocompatible	May cause irritation
Cost Efficiency	Reduces readmissions & treatment costs	Higher long-term expenses

Real-World Impact: Case Studies

Study 1: A 500-bed hospital reduced CAUTIs by 58% after introducing CovaGuard-coated catheters.
Study 2: A surgical centre cut SSI rates by 52% using ColActive Plus Ag dressings.

Where to Get Covalon's HAI Prevention Products?

Available through:
✔ Hospital procurement departments
✔ Medical distributors
✔ Direct orders via Covalon.com

For bulk inquiries or clinical trials, contact Covalon here.

Conclusion

HAIs are a preventable burden on patients and healthcare systems. Covalon's science-backed infection prevention technology products provide long-lasting, cost-effective protection where it matters most—catheters, wounds, and surgical sites.

Ready to reduce HAIs in your facility?
👉 Visit Covalon.com to explore solutions.